(Q44958914)

7 December 2017

Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture (English)

1 reference

acute myocardial infarction

7 December 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

5

1 reference

7 December 2017

8

Ursula Müller-Werdan

1 reference

7 December 2017

Ying Zhang

1

1 reference

7 December 2017

Katharina Köhler

2

1 reference

7 December 2017

Jia Xu

3

1 reference

7 December 2017

Di Lu

4

1 reference

7 December 2017

Axel Schlitt

6

1 reference

7 December 2017

Michael Buerke

7

1 reference

7 December 2017

Karl Werdan

9

1 reference

7 December 2017

Henning Ebelt

10

1 reference

7 December 2017

11 November 2010

1 reference

Journal of Molecular and Cellular Cardiology

7 December 2017

1 reference

7 December 2017

50

1 reference

7 December 2017

3

1 reference

7 December 2017

471-478

1 reference

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Cardiogenic differentiation and transdifferentiation of progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Myocyte apoptosis in heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

A mechanistic role for cardiac myocyte apoptosis in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Control of apoptosis by p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

The mitochondrial death pathway and cardiac myocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Survey of studies examining mammalian cardiomyocyte DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Optimized, highly efficient transfer of foreign genes into newborn mouse hearts in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

The homeobox gene Lbx1 specifies a subpopulation of cardiac neural crest necessary for normal heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

MMP induction and inhibition in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

The expanding universe of p53 targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Progressively developed myocardial apoptotic cell death during late phase of reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Role of collagen in acute myocardial infarct expansion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Anti-inflammatory effect of oxytocin in rat myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Healing after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.11.006

10.1016/J.YJMCC.2010.11.006

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference